ITMI20050891A1 - FORMULATIONS FOR THE TREATMENT OF PSORIASIS - Google Patents

FORMULATIONS FOR THE TREATMENT OF PSORIASIS

Info

Publication number
ITMI20050891A1
ITMI20050891A1 IT000891A ITMI20050891A ITMI20050891A1 IT MI20050891 A1 ITMI20050891 A1 IT MI20050891A1 IT 000891 A IT000891 A IT 000891A IT MI20050891 A ITMI20050891 A IT MI20050891A IT MI20050891 A1 ITMI20050891 A1 IT MI20050891A1
Authority
IT
Italy
Prior art keywords
psoriasis
formulations
treatment
Prior art date
Application number
IT000891A
Other languages
Italian (it)
Inventor
Nicola Nardiello
Original Assignee
Greenleaf S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenleaf S R L filed Critical Greenleaf S R L
Priority to IT000891A priority Critical patent/ITMI20050891A1/en
Priority to PCT/EP2006/004373 priority patent/WO2006122685A1/en
Priority to EP06753546A priority patent/EP1881833A1/en
Publication of ITMI20050891A1 publication Critical patent/ITMI20050891A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
IT000891A 2005-05-17 2005-05-17 FORMULATIONS FOR THE TREATMENT OF PSORIASIS ITMI20050891A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT000891A ITMI20050891A1 (en) 2005-05-17 2005-05-17 FORMULATIONS FOR THE TREATMENT OF PSORIASIS
PCT/EP2006/004373 WO2006122685A1 (en) 2005-05-17 2006-05-10 Compositions for the treatment of psoriasis
EP06753546A EP1881833A1 (en) 2005-05-17 2006-05-10 Compositions for the treatment of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000891A ITMI20050891A1 (en) 2005-05-17 2005-05-17 FORMULATIONS FOR THE TREATMENT OF PSORIASIS

Publications (1)

Publication Number Publication Date
ITMI20050891A1 true ITMI20050891A1 (en) 2006-11-18

Family

ID=36763953

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000891A ITMI20050891A1 (en) 2005-05-17 2005-05-17 FORMULATIONS FOR THE TREATMENT OF PSORIASIS

Country Status (3)

Country Link
EP (1) EP1881833A1 (en)
IT (1) ITMI20050891A1 (en)
WO (1) WO2006122685A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2959415B1 (en) 2010-04-30 2012-07-13 Ayawane DERMATOLOGICAL COMPOSITION BASED ON ARGAN OIL AND HYALURONIC ACID.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB643690A (en) * 1947-08-18 1950-09-27 Lilly Co Eli Improvements in or relating to a process of preparing a vitamin preparation and the product resulting therefrom
GB662485A (en) * 1948-08-27 1951-12-05 Lilly Co Eli Improvements in or relating to method of stabilizing vitamin solutions and the stabilized vitamin solutions resulting from said method
US3011944A (en) * 1956-07-21 1961-12-05 Zh Nagao Kenkyusho Composition for eliminating toxic effects of nicotine and method of using same
US3080292A (en) * 1960-07-12 1963-03-05 Hoffmann La Roche Stable pleasant-tasting vitamin b containing beadlets
FR4492M (en) * 1965-07-07 1966-10-10
JPS62258313A (en) * 1986-05-02 1987-11-10 Segawa Hiroki Cosmetic
JP3103396B2 (en) * 1990-07-20 2000-10-30 武田薬品工業株式会社 Bath agent
JPH0985161A (en) * 1995-09-28 1997-03-31 Kiteii:Kk Coating method of material
CA2178790A1 (en) * 1996-06-11 1997-12-12 Daniel L. Baier Control of diaper rash
NZ299412A (en) * 1996-09-19 1998-12-23 Al Sari Mishal Hamid Pharmaceutical compositions comprising a medicament derived from the leaves and flowers of nerrium oleander
US6107349A (en) * 1998-04-16 2000-08-22 Mantynen; Philip R. Method and composition for treating psoriasis
JP2002003377A (en) * 2000-06-20 2002-01-09 Taisho Pharmaceut Co Ltd Laxative formulated with picosulfate sodium
DE10053155A1 (en) * 2000-10-26 2002-05-08 Erika Jungkeit Treatment of psoriasis comprises administration of a multivitamin preparation containing vitamins B1, B2, B6, B12, C and E, nicotinamide, dexpanthenol, biotin and folic acid
ITBS20010027A1 (en) * 2001-03-23 2002-09-23 Gen Topics Srl ACTIVE INGREDIENT BASED ON LIPOIC ACID AND POLYENOLIC FATTY ACIDS
PL1708711T3 (en) * 2004-01-30 2010-10-29 Biotie Therapies Oyj Compositions useful especially for treatment or prevention of metabolic syndrome

Also Published As

Publication number Publication date
EP1881833A1 (en) 2008-01-30
WO2006122685A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
IL277406A (en) Novel use of il-1beta compounds
SMAP200900085A (en) 3-imidazolyl-indoles for the treatment of malolysiseproliferative
DK1868586T3 (en) Anti-inflammatory formulation
ITMO20050195A1 (en) MACHINE FOR EXTRACORPROUS TREATMENT OF BLOOD
CY2018006I1 (en) THERAPEUTIC FORMULATION OF CLADRIVINE FOR THE THERAPEUTIC TREATMENT OF PLAQUE STICHERONE
ITMI20031311A0 (en) FORMULATIONS FOR THE TREATMENT OF ARTHROTIC DISORDERS
ITRM20050179A1 (en) APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES.
ITMI20050891A1 (en) FORMULATIONS FOR THE TREATMENT OF PSORIASIS
EP1901765A4 (en) Intralesional treatment of psoriasis
ITMI20041941A1 (en) PROCESS FOR THE PREPARATION OF LYSOPOSPHATIDYLCHOLINE
ITMI20062049A1 (en) EQUIPMENT FOR FOOD TREATMENT
ITMI20052464A1 (en) PROCEDURE FOR THE PREPARATION OF NORELGESTROMIN NORELGESTROMINA
ITMI20040452A1 (en) PROCESS FOR THE PREPARATION OF OXCARBAZEPINA
ITMI20041086A1 (en) PROCEDURE FOR THE PREPARATION OF HYDROCARBALALOGENURI
ITMI20052419A1 (en) PROCESS FOR THE PREPARATION OF ANDROSTANIC CARBOTIOATES
DK1594498T3 (en) Use of etazolate for the treatment of diseases
FI20051058A0 (en) Process for the preparation of pure enantiomers
ITMI20040726A1 (en) PROCEDURE FOR THE PREPARATION OF MELATONIN
ITMI20040003A1 (en) PROCESS FOR THE PREPARATION OF 6-FLUORO-2-METHYL-1-INDANONE
SE0400574D0 (en) A novel pharmaceutical composition for the treatment of psoriasis
ITMI20040528A1 (en) LIGHT STIMULUS-EMITTER FOR THE TREATMENT OF PSYCHOPHYSICAL DISORDERS
ITGE20050087A1 (en) METHODOLOGY FOR THE PREPARATION OF A SUPER-DROPHOBIC TREATMENT
ITVR20050133A1 (en) STRUCTURE OF MONILE
ITVR20050140A1 (en) STRUCTURE OF TRAMEZZO
ITVI20050244A1 (en) STRUCTURE OF COLONNINA